Loading organizations...
§ Private Profile · Barcelona, Catalonia, Spain
Biotech company developing gene writing tools for the biopharmaceutical industry, focused on oncology, autoimmune, and genetic diseases.
Integra Therapeutics, a biotechnology company based in Barcelona, Spain, develops next-generation gene writing tools, such as its FiCAT platform, to improve the efficacy, precision, and safety of advanced therapies for oncology, autoimmune, and genetic diseases. The company has raised a total of €16.7 million through a €6 million seed round and a €10.7 million pre-Series A round to advance its preclinical development. Key investors include Columbus Venture Partners, AdBio Partners, and Takeda Ventures, with Professor George Church serving on its scientific advisory board and Miles Gerson as Independent Chairman. Spun out of Pompeu Fabra University, the company aims to transfer scientific knowledge to the biopharmaceutical industry. It was founded in 2020 by Dr. Marc Güell and Dr. Avencia Sánchez-Mejías.
Integra Therapeutics has raised $30.7M across 4 funding rounds.
Integra Therapeutics has raised $30.7M in total across 4 funding rounds.
Integra Therapeutics has raised $30.7M across 4 funding rounds. Most recently, it raised $12.5M Pre-Series A in September 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 8, 2025 | $12.5M Seed Plus | — | Advent France Biotechnology, Cdti, Columbus Venture Partners, Svetoslava Georgieva, Invivo Capital, Takeda Ventures | Announced |
| Jul 17, 2024 | $11.4M Grant | European Innovation Council | — | Announced |
| Mar 30, 2022 | $1.7M Seed | Damià Tormo | — | Announced |
| Dec 2, 2021 | $5.1M Seed | — | Lluis Pareras, Miles Gerson, Matthieu Coutet | Announced |
Integra Therapeutics has raised $30.7M in total across 4 funding rounds.
Integra Therapeutics's investors include Advent France Biotechnology, CDTI, Columbus Venture Partners, Svetoslava Georgieva, Invivo Capital, Takeda Ventures, European Innovation Council, Damià Tormo, Lluis Pareras, Miles Gerson, Matthieu Coutet.